These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33104036)

  • 1. The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy.
    Belter L; Jarecki J; Reyna SP; Cruz R; Jones CC; Schroth M; O'Toole CM; O'Brien S; Hall SA; Johnson NB; Paradis AD
    J Neuromuscul Dis; 2021; 8(1):109-123. PubMed ID: 33104036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members.
    Belter L; Cook SF; Crawford TO; Jarecki J; Jones CC; Kissel JT; Schroth M; Hobby K
    J Neuromuscul Dis; 2018; 5(2):167-176. PubMed ID: 29614694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada.
    McMillan HJ; Gerber B; Cowling T; Khuu W; Mayer M; Wu JW; Maturi B; Klein-Panneton K; Cabalteja C; Lochmüller H
    J Neuromuscul Dis; 2021; 8(4):553-568. PubMed ID: 33749617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community.
    Cruz R; Belter L; Wasnock M; Nazarelli A; Jarecki J
    Clin Ther; 2019 May; 41(5):943-960.e4. PubMed ID: 31056304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life data for individuals affected by spinal muscular atrophy: a baseline dataset from the Cure SMA Community Update Survey.
    Belter L; Cruz R; Jarecki J
    Orphanet J Rare Dis; 2020 Aug; 15(1):217. PubMed ID: 32838797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I have SMA, SMA doesn't have me": a qualitative snapshot into the challenges, successes, and quality of life of adolescents and young adults with SMA.
    Mazzella A; Curry M; Belter L; Cruz R; Jarecki J
    Orphanet J Rare Dis; 2021 Feb; 16(1):96. PubMed ID: 33618755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.
    Lusakowska A; Jedrzejowska M; Kaminska A; Janiszewska K; Grochowski P; Zimowski J; Sierdzinski J; Kostera-Pruszczyk A
    Orphanet J Rare Dis; 2021 Mar; 16(1):150. PubMed ID: 33761963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain.
    López-Bastida J; Peña-Longobardo LM; Aranda-Reneo I; Tizzano E; Sefton M; Oliva-Moreno J
    Orphanet J Rare Dis; 2017 Aug; 12(1):141. PubMed ID: 28821278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of patients with spinal muscular atrophy on the island of Shikoku, Japan.
    Okamoto K; Motoki T; Saito I; Urate R; Aibara K; Jogamoto T; Fukuda M; Wakamoto H; Maniwa S; Kondo Y; Toda Y; Goji A; Mori T; Soga T; Konishi Y; Nagai S; Takami Y; Tokorodani C; Nishiuchi R; Usui D; Ando R; Tada S; Yamanishi Y; Nagai M; Arakawa R; Saito K; Nishio H; Ishii E; Eguchi M
    Brain Dev; 2020 Sep; 42(8):594-602. PubMed ID: 32505480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early experiences of nusinersen for the treatment of spinal muscular atrophy: Results from a large survey of patients and caregivers.
    Chen E; Dixon S; Naik R; Noone JM; Buchenberger JD; Whitmire SM; Mills R; Arnold W
    Muscle Nerve; 2021 Mar; 63(3):311-319. PubMed ID: 33184859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of muscular dystrophy and spinal muscular atrophy in Croatia: data from national and non-governmental organization registries.
    Draušnik Ž; Cerovečki I; Štefančić V; Mihel S; Stevanović R; Barišić N; Matković H; Melša M; Mirić M; Pjevač N; Benjak T
    Croat Med J; 2019 Dec; 60(6):488-493. PubMed ID: 31894913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe.
    Bladen CL; Thompson R; Jackson JM; Garland C; Wegel C; Ambrosini A; Pisano P; Walter MC; Schreiber O; Lusakowska A; Jedrzejowska M; Kostera-Pruszczyk A; van der Pol L; Wadman RI; Gredal O; Karaduman A; Topaloglu H; Yilmaz O; Matyushenko V; Rasic VM; Kosac A; Karcagi V; Garami M; Herczegfalvi A; Monges S; Moresco A; Chertkoff L; Chamova T; Guergueltcheva V; Butoianu N; Craiu D; Korngut L; Campbell C; Haberlova J; Strenkova J; Alejandro M; Jimenez A; Ortiz GG; Enriquez GV; Rodrigues M; Roxburgh R; Dawkins H; Youngs L; Lahdetie J; Angelkova N; Saugier-Veber P; Cuisset JM; Bloetzer C; Jeannet PY; Klein A; Nascimento A; Tizzano E; Salgado D; Mercuri E; Sejersen T; Kirschner J; Rafferty K; Straub V; Bushby K; Verschuuren J; Beroud C; Lochmüller H
    J Neurol; 2014 Jan; 261(1):152-63. PubMed ID: 24162038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing perspectives of disease burden and clinically meaningful changes using the Spinal Muscular Atrophy Health Index in adolescents and young adults.
    Mazzella A; Cruz R; Belter L; Curry M; Dilek N; Zizzi C; Heatwole C; Jarecki J
    Muscle Nerve; 2022 Sep; 66(3):276-281. PubMed ID: 35616549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease burden of spinal muscular atrophy in Germany.
    Klug C; Schreiber-Katz O; Thiele S; Schorling E; Zowe J; Reilich P; Walter MC; Nagels KH
    Orphanet J Rare Dis; 2016 May; 11(1):58. PubMed ID: 27145956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children and young adults with spinal muscular atrophy treated with nusinersen.
    Osredkar D; Jílková M; Butenko T; Loboda T; Golli T; Fuchsová P; Rohlenová M; Haberlova J
    Eur J Paediatr Neurol; 2021 Jan; 30():1-8. PubMed ID: 33307321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health information literacy among children with spinal muscular atrophy and their caregivers.
    Zhang W; Feng Y; Yan Y; Yao M; Gao F; Lin W; Mao S
    Ital J Pediatr; 2024 Aug; 50(1):157. PubMed ID: 39183350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort.
    Jones CC; Cook SF; Jarecki J; Belter L; Reyna SP; Staropoli J; Farwell W; Hobby K
    J Neuromuscul Dis; 2020; 7(1):33-40. PubMed ID: 31707372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study.
    Zhang Y; He J; Zhang Y; Li L; Tang X; Wang L; Guo J; Jin C; Tighe S; Zhang Y; Zhu Y; Zhu B
    Medicine (Baltimore); 2020 Jan; 99(3):e18809. PubMed ID: 32011487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Burden of Spinal Muscular Atrophy on Informal Caregivers.
    Aranda-Reneo I; Peña-Longobardo LM; Oliva-Moreno J; Litzkendorf S; Durand-Zaleski I; Tizzano EF; López-Bastida J
    Int J Environ Res Public Health; 2020 Dec; 17(23):. PubMed ID: 33276656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Genotypes and Epidemiology of Spinal Muscular Atrophy in Greece: A Nationwide Study Spanning 24 Years.
    Kekou K; Svingou M; Sofocleous C; Mourtzi N; Nitsa E; Konstantinidis G; Youroukos S; Skiadas K; Katsalouli M; Pons R; Papavasiliou A; Kotsalis C; Pavlou E; Evangeliou A; Katsarou E; Voudris K; Dinopoulos A; Vorgia P; Niotakis G; Diamantopoulos N; Nakou I; Koute V; Vartzelis G; Papadimas GK; Papadopoulos C; Tsivgoulis G; Traeger-Synodinos J
    J Neuromuscul Dis; 2020; 7(3):247-256. PubMed ID: 32417790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.